These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18070958)

  • 1. In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2008 Feb; 52(2):761-6. PubMed ID: 18070958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
    Goldstein EJ; Citron DM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):447-54. PubMed ID: 19249176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
    Credito KL; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2008 Jan; 52(1):365-73. PubMed ID: 17938185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
    Wexler HM; Engel AE; Glass D; Li C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):919-24. PubMed ID: 2512142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Loza E; Morosini MI; Cantón R; Almaraz F; Reig M; Baquero F
    Rev Esp Quimioter; 2003 Jun; 16(2):209-15. PubMed ID: 12973459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of doripenem against anaerobic bacteria].
    Dubreuil L; Neut C; Mahieux S; Muller-Serieys C; Jean-Pierre H; Marchandin H; Soussy CJ; Miara A
    Pathol Biol (Paris); 2011 Apr; 59(2):102-7. PubMed ID: 20537808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of fungal and bacterial infections of the diabetic foot.
    Chincholikar DA; Pal RB
    Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
    J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
    Castanheira M; Jones RN; Livermore DM
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):426-33. PubMed ID: 19249180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
    Pillar CM; Torres MK; Brown NP; Shah D; Sahm DF
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4388-99. PubMed ID: 18779357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
    Pelak BA; Citron DM; Motyl M; Goldstein EJ; Woods GL; Teppler H
    J Antimicrob Chemother; 2002 Nov; 50(5):735-41. PubMed ID: 12407133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR; Stilwell MG; Jones RN
    Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.
    Goldstein EJ; Citron DM; Nesbit CA
    Diabetes Care; 1996 Jun; 19(6):638-41. PubMed ID: 8725864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.